Table 1.
γ = −1.5 | γ = 0 | |||||
---|---|---|---|---|---|---|
Method | Mean Est | SD Est | Mean SE | Mean Est | SD Est | Mean SE |
Standard Application of Methods | ||||||
Two-stage | −1.526 | 0.239 | 0.230 | −0.043 | 0.161 | 0.156 |
Seq Strat | −1.475 | 0.314 | 0.253 | 0.027 | 0.217 | 0.158 |
MSM | −1.259 | 0.358 | 0.318 | 0.060 | 0.296 | 0.254 |
MSM (obsPSA) | −1.228 | 0.385 | 0.314 | 0.065 | 0.291 | 0.243 |
| ||||||
Analysis Using True PSA | ||||||
Two-stage | −1.584 | 0.238 | 0.230 | −0.076 | 0.158 | 0.156 |
Seq Strat | −1.546 | 0.321 | 0.259 | −0.002 | 0.213 | 0.158 |
MSM | −1.272 | 0.356 | 0.318 | 0.015 | 0.293 | 0.253 |
| ||||||
Standard Application: Results for n=5000 | ||||||
Two-stage | −1.513 | 0.104 | 0.102 | −0.039 | 0.069 | 0.070 |
Seq Strat | −1.442 | 0.211 | 0.174 | 0.031 | 0.095 | 0.069 |
MSM | −1.246 | 0.259 | 0.185 | 0.014 | 0.238 | 0.157 |
| ||||||
Analysis Using True SADT Probabilities | ||||||
MSM | −1.290 | 0.434 | 0.327 | 0.014 | 0.335 | 0.256 |
| ||||||
Analysis Using Random Treatment Times | ||||||
Two-stage | −1.411 | 0.226 | 0.209 | 0.022 | 0.140 | 0.132 |
Seq Strat | −1.387 | 0.252 | 0.213 | 0.057 | 0.166 | 0.131 |
MSM | −1.269 | 0.214 | 0.204 | −0.028 | 0.130 | 0.131 |
Unweighted MSM | −1.271 | 0.218 | 0.204 | −0.030 | 0.137 | 0.131 |